CIK 0001412486 · Non-accelerated filer<br>Smaller reporting company
Cocrystal Pharma, Inc.
Sign in to watch- Ticker
- COCP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 352528215
- Phone
- (786) 459-1831
- Business address
- 19805 N. CREEK PARKWAY, BOTHELL, WA, 98011
- Former names
- BIOZONE PHARMACEUTICALS, INC., International Surf Resorts, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-04 | Schinazi Raymond F 10% owner | Sale | −575,000 | $2.95 | $1.7M | 7,674,960 |
| 2020-06-22 | Lee Sam President | Grant or award · Stock Options (Right to Buy) | +100,000 | 100,000 | ||
| 2020-06-22 | Japour Anthony J Director | Grant or award · Stock Options (Right to Buy) | +56,000 | 56,000 | ||
| 2020-06-22 | WILCOX GARY Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +200,000 | 200,000 | ||
| 2020-06-22 | Kornberg Roger D. Director | Grant or award · Stock Options (Right to Buy) | +50,000 | 50,000 | ||
| 2020-06-22 | Martin James Joseph Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +150,000 | 150,000 | ||
| 2020-06-22 | FROST PHILLIP MD ET AL Director | Grant or award · Stock Options (Right to Buy) | +50,000 | 50,000 | ||
| 2020-06-22 | Rubin Steven D Director | Grant or award · Stock Options (Right to Buy) | +72,000 | 72,000 | ||
| 2019-10-25 | Schinazi Raymond F 10% owner | Purchase | +7,906 | $1.15 | $9K | 9,257,863 |
| 2019-10-24 | Schinazi Raymond F 10% owner | Purchase | +5,094 | $1.15 | $6K | 9,249,957 |
| 2019-10-23 | Schinazi Raymond F 10% owner | Purchase | +3,935 | $1.04 | $4K | 9,244,863 |
| 2018-09-21 | HSIAO JANE PH D Director | Grant or award · Stock Options (Right to Buy) | +50,000 | 50,000 | ||
| 2018-09-21 | Lee Sam President | Grant or award · Stock Options (Right to Buy) | +100,000 | 100,000 | ||
| 2018-09-21 | Rubin Steven D Director | Grant or award · Stock Options (Right to Buy) | +50,000 | 50,000 | ||
| 2018-09-21 | FROST PHILLIP MD ET AL Director | Grant or award · Stock Options (Right to Buy) | +50,000 | 50,000 | ||
| 2018-09-21 | Schinazi Raymond F Director | Grant or award · Stock Options (Right to Buy) | +50,000 | 50,000 | ||
| 2018-09-21 | BLOCK DAVID S Director | Grant or award · Stock Options (Right to Buy) | +50,000 | 50,000 | ||
| 2018-09-21 | WILCOX GARY Interim CEO | Grant or award · Stock Options (Right to Buy) | +200,000 | 200,000 | ||
| 2018-09-21 | Martin James Joseph Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +150,000 | 150,000 | ||
| 2018-05-10 | Schinazi Raymond F Director | Option exercise | +263,158 | $1.90 | $500K | 985,384 |
Page 4 of 8 · 145 trades